Online Only Articles

Efficacy of venetoclax monotherapy in patients with relapsed, refractory mantle cell lymphoma after Bruton tyrosine kinase inhibitor therapy

Department of Haematology, Churchill Hospital, Oxford University Hospitals NHS Foundation Trust
The Ernest and Helen Scott Haematological Research Institute, University of Leicester
Department of Haematology, The Royal Marsden Hospital, London
Department of Haematology, Addenbrooke’s Hospital NHS Trust, Cambridge
Department of Haematology, The Royal Marsden Hospital, London
Department of Haematology, Nottingham University Hospitals NHS Trust
Department of Haematology, Ipswich Hospital
Department of Haematology, NHS Tayside, Dundee
Department of Haematology, Western Sussex Hospitals NHS Foundation Trust, Worthing
Department of Haematology, Ipswich Hospital
The Ernest and Helen Scott Haematological Research Institute, University of Leicester
Department of Haematology, Churchill Hospital, Oxford University Hospitals NHS Foundation Trust
Vol. 104 No. 2 (2019): February, 2019 https://doi.org/10.3324/haematol.2018.198812